NASDAQ

XOMA Presents Positive Data from PTH1R Monoclonal Antibody Program

BERKELEY, Calif., April 18, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in ...

XOMA Presents Positive Data from PTH1R Monoclonal Antibody Program

BERKELEY, Calif., April 18, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in ...

XOMA Presents Positive Data from PTH1R Monoclonal Antibody Program

BERKELEY, Calif., April 18, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in ...

XOMA Presents Positive Data from PTH1R Monoclonal Antibody Program

BERKELEY, Calif., April 18, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in ...

Avadel Pharmaceuticals to Report First Quarter 2017 Results

DUBLIN, Ireland, April 17, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced it ...

Avadel Pharmaceuticals to Report First Quarter 2017 Results

DUBLIN, Ireland, April 17, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced it ...

Oncobiologics Secures Additional Funding

CRANBURY, N.J., April 17, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...

Oncobiologics Secures Additional Funding

CRANBURY, N.J., April 17, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...

OncoMed’s Phase 2 Trial of Tarextumab in Small Cell Lung Cancer Does Not Meet Endpoints

Company also Announces Discontinuation of Brontictuzumab Phase 1b Study OncoMed Management to Host Conference ...